The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression

by Viktor Umansky, Carolin Blattner, Christoffer Gebhardt, Jochen Utikal
Published 2016-11-01

Expression of Neural Crest Markers GLDC and ERRFI1 is Correlated with Melanoma Prognosis

by Katharina Jäger, Lionel Larribère, Huizi Wu, Christel Weiss, Christoffer Gebhardt, Jochen Utikal
Published 2019-01-01

Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma

by Glenn Geidel, Isabel Heidrich, Julian Kött, Stefan W. Schneider, Klaus Pantel, Christoffer Gebhardt
Published 2022-03-01

Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance?

by Chiara L. Blomen, Julian Kött, Tabea I. Hartung, Leopold K. Torster, Christoffer Gebhardt
Published 2021-12-01

Long-Term Management of Advanced Basal Cell Carcinoma: Current Challenges and Future Perspectives

by Markus V. Heppt, Christoffer Gebhardt, Jessica C. Hassel, Mareike Alter, Ralf Gutzmer, Ulrike Leiter, Carola Berking
Published 2022-09-01

Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy

by Raphael Reinhard, MD, Christoffer Gebhardt, MD, Nolwenn Maurier, MD, Lionel Larribère, PhD, Azadeh Orouji, MD, Jochen Utikal, MD
Published 2018-03-01

Successful treatment of refractory checkpoint inhibitor‐induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab

by Inga Hansen, Julian Kött, Silke Heidenreich, Francis A. Ayuk, Patricia Doll, Finn Abeck, Nina Booken, Christoffer Gebhardt, Stefan W. Schneider
Published 2024-03-01

Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response

by Mathias Bernhardt, Daniel Novak, Yassen Assenov, Elias Orouji, Nathalie Knappe, Kasia Weina, Maike Reith, Lionel Larribere, Christoffer Gebhardt, Christoph Plass, Viktor Umansky, Jochen Utikal
Published 2017-05-01

Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma

by Nadine L. Ammann, Yasmin F. Schwietzer, Christian Mess, Julia-Christina Stadler, Glenn Geidel, Julian Kött, Klaus Pantel, Stefan W. Schneider, Jochen Utikal, Alexander T. Bauer, Christoffer Gebhardt
Published 2022-11-01

Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients

by Viola K. DeTemple, Jessica C. Hassel, Michael M. Sachse, Imke Grimmelmann, Ulrike Leiter, Christoffer Gebhardt, Julia Eckardt, Claudia Pföhler, Yenny Angela, Hanna Hübbe, Ralf Gutzmer
Published 2022-11-01

High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy

by Julian Kött, Inka Lilott Hoehne, Isabel Heidrich, Noah Zimmermann, Kim-Lea Reese, Tim Zell, Glenn Geidel, Alessandra Rünger, Stefan W. Schneider, Klaus Pantel, Daniel J. Smit, Christoffer Gebhardt
Published 2024-04-01

Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG

by Dirk Schadendorf, Lisa Zimmer, Bastian Schilling, Selma Ugurel, Valerie Glutsch, Anja Gesierich, Matthias Goebeler, Jürgen C Becker, Sebastian Haferkamp, Christian Posch, Michael Weichenthal, Ulrike Leiter, Christoffer Gebhardt, Patrick Schummer, Hermann Kneitz, Detlef Klein
Published 2022-11-01

Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies

by Nikolaus B. Wagner, Benjamin Weide, Mirko Gries, Maike Reith, Kathrin Tarnanidis, Valerie Schuermans, Charlotte Kemper, Coretta Kehrel, Anne Funder, Ramtin Lichtenberger, Antje Sucker, Esther Herpel, Tim Holland-Letz, Dirk Schadendorf, Claus Garbe, Viktor Umansky, Jochen Utikal, Christoffer Gebhardt
Published 2019-12-01

Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors

by Stefan W Schneider, Klaus Pantel, Christoffer Gebhardt, Robin Reschke, Christian Mess, Julia-Christina Stadler, Laura Keller, Alexander T Bauer, Julian Koett, Glenn Geidel, Isabel Heidrich, Sabine Vidal-y-Sy, Antje Andreas, Carlotta Stramaglia, Mark Sementsov, Wiebcke Haberstroh, Benjamin Deitert, Inka Lilott Hoehne, Thomas Haalck
Published 2023-05-01

Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the Germa...

by Maximilian Haist, Henner Stege, Berenice Mareen Lang, Aikaterini Tsochataridou, Martin Salzmann, Peter Mohr, Dirk Schadendorf, Selma Ugurel, Jan-Malte Placke, Michael Weichenthal, Ralf Gutzmer, Ulrike Leiter, Martin Kaatz, Sebastian Haferkamp, Carola Berking, Markus Heppt, Barbara Tschechne, Patrick Schummer, Christoffer Gebhardt, Stephan Grabbe, Carmen Loquai
Published 2022-11-01

Pre‐analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients

by Svenja Schneegans, Lelia Lück, Katharina Besler, Leonie Bluhm, Julia‐Christina Stadler, Janina Staub, Rüdiger Greinert, Beate Volkmer, Mikael Kubista, Christoffer Gebhardt, Alexander Sartori, Darryl Irwin, Elina Serkkola, Taija afHällström, Evi Lianidou, Markus Sprenger‐Haussels, Melanie Hussong, Peter Mohr, Stefan W. Schneider, Jonathan Shaffer, Klaus Pantel, Harriet Wikman
Published 2020-05-01

Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients

by Georg Lodde, Andrea Forschner, Jessica Hassel, Lena M. Wulfken, Friedegund Meier, Peter Mohr, Katharina Kähler, Bastian Schilling, Carmen Loquai, Carola Berking, Svea Hüning, Kerstin Schatton, Christoffer Gebhardt, Julia Eckardt, Ralf Gutzmer, Lydia Reinhardt, Valerie Glutsch, Ulrike Nikfarjam, Michael Erdmann, Andreas Stang, Bernd Kowall, Alexander Roesch, Selma Ugurel, Lisa Zimmer, Dirk Schadendorf, Elisabeth Livingstone
Published 2021-05-01

CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis

by Desiree Loreth, Moritz Schuette, Jenny Zinke, Malte Mohme, Andras Piffko, Svenja Schneegans, Julia Stadler, Melanie Janning, Sonja Loges, Simon A. Joosse, Katrin Lamszus, Manfred Westphal, Volkmar Müller, Markus Glatzel, Jakob Matschke, Christoffer Gebhardt, Stefan W. Schneider, Iwona Belczacka, Beate Volkmer, Rüdiger Greinert, Marie-Laure Yaspo, Patrick N. Harter, Klaus Pantel, Harriet Wikman
Published 2021-06-01

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study

by Carola Berking, Thomas K Eigentler, Andrea Forschner, Georg Richtig, Erika Richtig, Stefan Diem, Benjamin Weide, Bernhard Klumpp, Claus Garbe, Lukas Flatz, Patrick Terheyden, Lydia Reinhardt, Friedegund Meier, Carmen Loquai, Ulrike Leiter, Van Anh Nguyen, Martin Röcken, Mirjana Ziemer, Nikolaus B Wagner, Max M Lenders, Kathrin Kühl, Fiona André, Milena Dudda, Natalie Ring, Chiara Ebel, Ramon Stäger, Caroline Zellweger, Roland Lang, Michael Paar, Philipp Gussek, Suzan H Stürmer, Susanne Kimeswenger, Angela Oellinger, Maximilian Gassenmaier, Amadeus Schraag, Wolfram Hoetzenecker, Johanna Mangana, Christoffer Gebhardt, Antonio Cozzio
Published 2021-05-01

Treatment management for BRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG

by Dirk Schadendorf, Carola Berking, Jessica C Hassel, Lisa Zimmer, Ralf Gutzmer, Alexander Kreuter, Andrea Forschner, Bastian Schilling, Selma Ugurel, Katharina C Kähler, Peter Mohr, Patrick Terheyden, Felix Kiecker, Henner Stege, Sebastian Haferkamp, Friedegund Meier, Claudia Pfoehler, Dirk Debus, Rudolf Herbst, Carmen Loquai, Frank Meiss, Martin Kaatz, Jens Ulrich, Edgar Dippel, Michael Weichenthal, Axel Hauschild, Ulrike Leiter, Markus V Heppt, Christoffer Gebhardt, Michael Sachse, Fabian Ziller, Stephan Grabbe, Georg Lodde, Maximilian Haist, Friederike Rogall, Yuqi Tan, Imke von Wasielewski, Kai Christian Klespe, Michael Tronnier, Jan Christoph Simon
Published 2023-09-01